Voorbeelden van het gebruik van Zelboraf in het Engels en hun vertalingen in het Nederlands
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
What is Zelboraf?
Zelboraf 240 mg film-coated tablets.
How does Zelboraf work?
Other information about Zelboraf.
How is Zelboraf used?
Zelboraf 240 mg tablets vemurafenib.
What is Zelboraf used for?
Zelboraf 240 mg film-coated tablets vemurafenib.
What benefit has Zelboraf shown during the studies?
This may affect the activity of Zelboraf.
How has Zelboraf been studied?
It is not known whether the ingredients in Zelboraf pass into human milk.
Why has Zelboraf been approved?
are going to have radiotherapy, as Zelboraf may worsen radiation treatment side effects.
Do not take Zelboraf regularly on an empty stomach.
Worsening of radiation treatment side effects can occur in patients who are treated with radiation before, during, or after Zelboraf treatment.
What Zelboraf looks like and contents of the pack?
Each dose can be taken with or without food, but Zelboraf should be taken in the same way day-to-day.
Zelboraf is a medicine that contains the active substance vemurafenib.
The combination of this medicine with Zelboraf is not recommended due to increased toxicity to the liver.
Zelboraf 240 mg film-coated tablets are pinkish white to orange white.
The Committee concluded that benefits of Zelboraf are greater than its risks
Zelboraf is an anticancer medicine that contains the active substance vemurafenib.
around half of the patients taking Zelboraf experienced a severe side effect
Zelboraf has side effects that can affect your ability to drive
If you take more Zelboraf than you should, talk to your doctor immediately.
Zelboraf is only given to patients whose melanoma tumours are caused by the BRAF V600 mutation.
Some patients treated with Zelboraf develop another type of skin cancer called‘cutaneous squamous cell carcinoma' which is successfully treated by local surgery.
Zelboraf was shown to be effective at prolonging patients' lives and delaying the worsening of the disease.
The CHMP noted that Zelboraf had been convincingly shown to improve overall survival